Csajka C - Search Results

1

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.

Monfort A, Cardoso E, Eap CB, Fischer Fumeaux CJ, Graz MB, Morisod Harari M, Weisskopf E, Gandia P, Allegaert K, Nordeng H, Hascoët JM, Claris O, Epiney M, Csajka C, Guidi M, Ferreira E, Panchaud A. Monfort A, et al. Among authors: csajka c. Front Psychiatry. 2023 May 18;14:1167870. doi: 10.3389/fpsyt.2023.1167870. eCollection 2023. Front Psychiatry. 2023. PMID: 37275991 Free PMC article.

2

Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

Csajka C, Buclin T, Brunner HR, Biollaz J. Csajka C, et al. Clin Pharmacokinet. 1997 Jan;32(1):1-29. doi: 10.2165/00003088-199732010-00001. Clin Pharmacokinet. 1997. PMID: 9012554 Review.

3

Imatinib plasma levels: correlation with clinical benefit in GIST patients.

Widmer N, Decosterd LA, Csajka C, Montemurro M, Haouala A, Leyvraz S, Buclin T. Widmer N, et al. Among authors: csajka c. Br J Cancer. 2010 Mar 30;102(7):1198-9. doi: 10.1038/sj.bjc.6605584. Epub 2010 Feb 23. Br J Cancer. 2010. PMID: 20179709 Free PMC article. No abstract available.

4

Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Csajka C, Verotta D. Csajka C, et al. J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. doi: 10.1007/s10928-005-9002-0. Epub 2006 Jan 11. J Pharmacokinet Pharmacodyn. 2006. PMID: 16404503 Review.

5

Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.

Lisibach A, Benelli V, Ceppi MG, Waldner-Knogler K, Csajka C, Lutters M. Lisibach A, et al. Among authors: csajka c. Eur J Clin Pharmacol. 2021 Feb;77(2):147-162. doi: 10.1007/s00228-020-02994-x. Epub 2020 Oct 3. Eur J Clin Pharmacol. 2021. PMID: 33011824 Free PMC article.

6

Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.

Klopp-Schulze L, Joerger M, Wicha SG, Ter Heine R, Csajka C, Parra-Guillen ZP, Kloft C. Klopp-Schulze L, et al. Among authors: csajka c. Clin Pharmacokinet. 2018 Feb;57(2):229-242. doi: 10.1007/s40262-017-0555-z. Clin Pharmacokinet. 2018. PMID: 28540639

7

Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.

Lamoth F, Buclin T, Csajka C, Pascual A, Calandra T, Marchetti O. Lamoth F, et al. Among authors: csajka c. Antimicrob Agents Chemother. 2009 Feb;53(2):785-7. doi: 10.1128/AAC.00891-08. Epub 2008 Dec 1. Antimicrob Agents Chemother. 2009. PMID: 19047655 Free PMC article.

8

Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

Csajka C, Haller CA, Benowitz NL, Verotta D. Csajka C, et al. Br J Clin Pharmacol. 2005 Mar;59(3):335-45. doi: 10.1111/j.1365-2125.2005.02254.x. Br J Clin Pharmacol. 2005. PMID: 15752380 Free PMC article.

9

The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Csajka C, Drover D, Verotta D. Csajka C, et al. Pharm Res. 2005 Aug;22(8):1227-35. doi: 10.1007/s11095-005-5266-8. Epub 2005 Aug 3. Pharm Res. 2005. PMID: 16078132

10

Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.

Brioschi Guevara A, Bieler M, Altomare D, Berthier M, Csajka C, Dautricourt S, Démonet JF, Dodich A, Frisoni GB, Miniussi C, Molinuevo JL, Ribaldi F, Scheltens P, Chételat G. Brioschi Guevara A, et al. Among authors: csajka c. Alzheimers Res Ther. 2021 Oct 11;13(1):172. doi: 10.1186/s13195-021-00844-1. Alzheimers Res Ther. 2021. PMID: 34635149 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page